Biophysical evidence of two docking sites of the carboxyl heptad repeat region within the amino heptad repeat region of gp41 of human immunodeficiency virus type 1

被引:14
作者
Chang, Ding-Kwo [1 ]
Hsu, Chang-Sheng [1 ]
机构
[1] Acad Sinica, Inst Chem, Taipei 11529, Taiwan
关键词
heptad repeat region; helix bundle; fusion inhibitor; HIV-1; gp41 hydrophobic pocket; turbidity clearance; surface plasmon resonance; bi-modal binding;
D O I
10.1016/j.antiviral.2006.12.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two HIV-1 gp41-derived peptide fusion inhibitors, T-20 and T-649, were synthesized and their binding profiles of the N-heptad repeat region (HR1) were compared to examine the molecular basis of the differential antiviral potency and viral resistance. Turbidity clearance experiments based on the overlapping 15-mer peptides derived from HR1 revealed a major binding site at the LLSGIV segment for both T-20 and T-649. Additionally, another docking site was found at the sequence encompassing the hydrophobic pocket of HR1 for T-649. Concordant results were observed from the surface plasmon resonance measurements. The binding affinity profile exhibited a major maximum around the LLSGIV motif for the two peptide fusion inhibitors while a less prominent docking region was located near the hydrophobic pocket for T-649. This bi-modal model deduced from T-20 and T-649 interaction with HR1 peptides could rationalize the failure of emergence of the fusion inhibitor-resistant virus with simultaneous mutations in each of the two binding regions, as well as the generally higher potency of T-649 against most viral strains. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 30 条
[1]   The anti-HIV activity of ADS-J1 targets the HIV-1 gp120 [J].
Armand-Ugón, M ;
Clotet-Codina, I ;
Tintori, C ;
Manetti, F ;
Clotet, B ;
Botta, M ;
Esté, JA .
VIROLOGY, 2005, 343 (01) :141-149
[2]   HIV-1 resistance to the gp41-dependent fusion inhibitor C-34 [J].
Armand-Ugón, M ;
Gutiérrez, A ;
Clotet, B ;
Esté, JA .
ANTIVIRAL RESEARCH, 2003, 59 (02) :137-142
[3]   Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 [J].
Caffrey, M ;
Cai, ML ;
Kaufman, J ;
Stahl, SJ ;
Wingfield, PT ;
Covell, DG ;
Gronenborn, AM ;
Clore, GM .
EMBO JOURNAL, 1998, 17 (16) :4572-4584
[4]   EFFECTS OF AMINO-ACID CHANGES IN THE EXTRACELLULAR DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 ENVELOPE GLYCOPROTEIN [J].
CAO, J ;
BERGERON, L ;
HELSETH, E ;
THALI, M ;
REPKE, H ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2747-2755
[5]   Natural resistance-associated mutations to enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients [J].
Carmona, R ;
Pérez-Alvarez, L ;
Muñoz, M ;
Casado, G ;
Delgado, E ;
Sierra, M ;
Thomson, M ;
Vega, Y ;
de Parga, EV ;
Contreras, G ;
Medrano, L ;
Nájera, R .
JOURNAL OF CLINICAL VIROLOGY, 2005, 32 (03) :248-253
[6]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[7]   Biophysical characterization of the structure of the amino-terminal region of gp41 of HIV-1 - Implications on viral fusion mechanism [J].
Chang, DK ;
Cheng, SF ;
Trivedi, VD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (09) :5299-5309
[8]   Effect of naturally-occurring gp41 HR1 variations on susceptibility of HIV-1 to fusion inhibitors [J].
Chinnadurai, R ;
Münch, J ;
Kirchhoff, F .
AIDS, 2005, 19 (13) :1401-1405
[9]   Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor [J].
Derdeyn, CA ;
Decker, JM ;
Sfakianos, JN ;
Zhang, ZJ ;
O'Brien, WA ;
Ratner, L ;
Shaw, GM ;
Hunter, E .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8605-8614
[10]   The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation [J].
Dwyer, JJ ;
Hasan, A ;
Wilson, KL ;
White, JM ;
Matthews, TJ ;
Delmedico, MK .
BIOCHEMISTRY, 2003, 42 (17) :4945-4953